SBI Securities
OBX icon

SBI Securities’s Obsidian Therapeutics OBX Stock Holding History

SBI Securities’s Portfolio OBX Stock Details OBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14 Buy
+1
New +$20 ﹤0.01% 3973

Other funds holding OBX

Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Revelation Capital Management
Revelation Capital Management Sausalito, California $8.01M AUM 49.3% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

SBI Securities's OBX Position: Q3 2026 in Review

SBI Securities opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 1 share worth $14. The stake represents ﹤0.01% of the portfolio and ranks #3973 among its holdings.

8 funds tracked by Wall St. Rank hold OBX as of Q3 2026.

  • SBI Securities held 1 share of Obsidian Therapeutics worth $14 as of Q3 2026.
  • Obsidian Therapeutics was a new SBI Securities position in Q3 2026.
  • Obsidian Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3973 holding.
  • 8 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.